NCT03833700View on ClinicalTrials.gov

A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Solid NeoplasmsColorectal NeoplasmsGastrointestinal Tumors
Interventions
DRUG

E7386

E7386 doses.

Trial Locations (8)

Unknown

Eisai Trial Site#7, Nagoya

Eisai Trial Site #2, Kashiwa

Eisai Trial Site #5, Sapporo

Eisai Trial Site#8, Sendai

Eisai Trial Site #3, Nagaizumi-cho

Eisai Trial Site #1, Chuo Ku

Eisai Trial Site #4, Fukuoka

Eisai Trial Site#6, Osaka

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY